Clinical Trial

Indocyanine Green Fluorescence in Evaluation of Pancreatic Remnant Perfusion.

Recruiting
View on ClinicalTrials.gov →
Summary
Main goal of this study is to evaluate the blood flow in a post resection pancreatic remnant after pancreaticoduodenectomy with use of indocyanine green fluorescence. If the hypothesis will be proven, evaluation of perfusion of the pancreatic remnant with indocyanine green could be used to estimate the increased risk of the development of pancreatic fistula.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-01-08.
Status change: Not Yet Recruiting → Recruiting 2024-08-19
Trial Details
NCT Number NCT06198400
Lead Sponsor Charles University, Czech Republic
Conditions Pancreatic Fistula
Enrollment 60 participants
Start Date 2024-05-01
Primary Completion 2027-01-01 (estimated)
Study Completion 2027-07-01 (estimated)
Updated on ClinicalTrials.gov 2024-08-21